Chuck Royce's ADMA Position Overview
Chuck Royce (via Royce & Associates Lp) currently holds 932.1K shares of ADMA Biologics, Inc. (ADMA) worth $13.66 M, representing 0.14% of the portfolio. First purchased in 2024-Q4, this short-term holding has been held for 4 quarters.
Based on 13F filings, Chuck Royce has maintained this position in ADMA for several quarters, showing initial confidence in the investment. Largest addition occurred in Q3 2025, adding 292.8K shares. Largest reduction occurred in Q2 2025, reducing 57.8K shares.
Analysis based on 13F filings available since 2013 Q2
Chuck Royce's ADMA Biologics (ADMA) Holding Value Over Time
Track share changes against reported price movement
Quarterly ADMA Biologics (ADMA) Trades by Chuck Royce
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2024 | +420,569 | New Buy | 420,569 | $17.15 |
| Q1 2025 | +276,432 | Add 65.73% | 697,001 | $19.84 |
| Q2 2025 | -57,752 | Reduce 8.29% | 639,249 | $18.21 |
| Q3 2025 | +292,819 | Add 45.81% | 932,068 | $14.66 |
Chuck Royce's ADMA Biologics Investment FAQs
Chuck Royce first purchased ADMA Biologics, Inc. (ADMA) in Q4 2024, acquiring 420,569 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Chuck Royce has held ADMA Biologics, Inc. (ADMA) for 4 quarters since Q4 2024. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Chuck Royce's largest addition to ADMA Biologics, Inc. (ADMA) was in Q4 2024, adding 420,569 shares worth $7.21 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Chuck Royce's firm, Royce & Associates Lp, owns 932,068 shares of ADMA Biologics, Inc. (ADMA), valued at approximately $13.66 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, ADMA Biologics, Inc. (ADMA) represents approximately 0.14% of Chuck Royce's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Chuck Royce's peak holding in ADMA Biologics, Inc. (ADMA) was 932,068 shares, as reported at the end of Q3 2025. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.